Yes I know Im on holiday so Ill make it quick. Just had a phone call and an e- mail from a City pal of mine and hes drooling over this company. Hes a trust worthy chap and has given me some fantastic tips over the last 10 years.
Hes going on about it being a ten bagger, but I dont like that kind of talk, best to just see how the market rates it. He says theres going to be a lot of news flow so that should provide for a momentum driven price. Have to say I have never known him quite so excited about a stock. Ive just gone in and bought a nice holding.

Heres the e-mail he sent me. It might be worth your while having a dabble. Citywire seem to think its going to be a hit.

Health minnow makes strong return to market
Published: 11:51 Wed 22 Oct 2003
By Joanne Wallen, Associate Editor
Email to a friend


The chief of Healthcare Enterprise Group sold his last business to private healthcare firm Bupa and he's now raring to go again; the business may be worth a second look.

Shares in the 24 million AIM-listed business were suspended in August pending a couple of key acquisitions, and returned to the market on Monday after the deals were announced.


Healthcare Enterprise Group (HCEG) (HCEG) paid a total of 11.5 million for the Safa Group and Industrial Pharmaceutical Service (IPS) as well as a 60.7% stake in SafaTec. The company raised a total of 10 million via a placing of shares at 1p to fund the acquisitions and also took on 3.5 million of bank debt.


Chairman Stuart Bruck, who previously founded private medical services business Barbican, which he sold to Bupa in January 1999, is hoping to build a significant business providing medical services to corporate customers. He is hoping to be a consolidator in what he told Citywire is a very fragmented market.


Both Safa and IPS provide first aid kits, training, first aid suites and a host of other medical and occupational health services to large corporate customers such as British Airways, Marks & Spencer, BT, Sainsbury and government procurement agency OGC. Both companies also have advanced 'replenishment systems,' which enable companies to maintain adequate supplies to satisfy UK health and safety legislation.


Bruck said these acquisitions would provide a 'platform' for further acquisitions.


The company had previously accrued minority stakes in a total of 14 small healthcare services companies in the UK and the US. In March it listed on AIM by reversing into a cash shell.


Bruck said the minority stakes offered it an entry into the market, but the company has now decided to focus on wholly operating and owning businesses. It has therefore identified four of its US businesses that it would like to buy the remaining stakes in. These are all within a two hour drive of the company's Los Angeles office, and would be run from there.


The company has also 'packaged up' the remaining eight businesses with a view to selling each of its minority stakes. Bruck said the pricing being talked about is already ahead of the indicative pricing given in March.


Safa and IPS apparently already have a 30% share of the corporate medical services market in the UK. They are both cash generative from operating activities. Both companies are based in the North of England and do not have a huge penetration in London, where Bruck believes the company has 'a huge opportunity.'


He reckons they have so far penetrated around 50% of the FTSE 100, and therefore have a 'great client base' to which they should be able to sell additional services.

SafaTec has interests in a number of early stage companies that have developed some innovative healthcare products and technologies, which the company is hoping to commercialise. For example, Safa has secured a sole international distribution agreement with Ebiox, a manufacturer of a unique decontaminant and cleansing product range based on a patented formula. SafaTec UK has a 35% interest in Ebiox and HCEG is negotiating to acquire a controlling interest for the enlarged Group.


Bruck does not expect to make any more major acquisitions in the next year or so, but thinks there are a lot of small players that the company might be able to mop up.


'This is very exciting, I am looking forward to digging in,' he said.


Shares are currently at 1.7p.


Citywire Verdict:


The corporate healthcare market is becoming increasingly regulated, which favours HCEG. Bruck's track record should also be worth buying into.


The corporate structure looks pretty complicated at present with all of the minority shareholdings, but Bruck now seems keen to get the point quickly where HCEG controls the majority of the businesses it operates.


This is obviously early days, but for anyone that fancies a speculative punt on a penny share, HCEG is worth a second look.ENDS.

Well it looks very good to me although its a speculative punt, what isnt in the markets today. Good chance to get on board aswell on a bad day.

Please DYOR. You are responsible for your own buying and selling actions.

GF.

SORRY FOR MY PROJECTION TODAY,ITS BETTER TO KEEP THE MOUTH SHUT WHEN A SHARE IS RISING.

This should answer your question.


Healthcare Enterprise Group PLC
07 March 2005

Healthcare Enterprise Group PLC

Allotment of shares

Further to the announcement of 8th and 17th November 2004 relating to the
acquisition of the entire share capital of DistriMatch GmbH, Healthcare
Enterprise Group PLC announces that application has been made for 163,042
ordinary shares to be admitted to the London Stock Exchange for trading on AIM.
The ordinary shares will commence trading on AIM on 9th March 2005, bringing the
issued share capital of Healthcare Enterprise Group PLC to 150,000,860.

7th March 2005

Enquiries:

Healthcare Enterprise Group PLC 020 7351 7500
John Bradshaw, Group Finance Director

The issue of that amount of shares is irrelevant. Think more along the lines of fear and greed and retail nervousness.

nothing climbs forever and the fever has begun to be tempered maybe things will settle down until the next bug hits them.

Healthcare Enterprise Group PLC
08 March 2005


Healthcare Enterprise Group PLC

Grant of Options


Healthcare Enterprise Group PLC, the healthcare products and services company
announces that on 1 March 2005, following an annual remuneration review, it
granted options to John Bradshaw, Group Finance Director, who joined the Board
on 3 January 2005. He has been granted options over 1,000,000 ordinary shares
at an exercise price of 79.25p per share, being the closing price preceding the
date of grant. The options vest equally on the first, second and third
anniversaries of grant and expire if unexercised upon the tenth anniversary from
the date of grant.

8 March 2005


Enquiries:

Healthcare Enterprise Group 020 7351 7500
Stuart Bruck, Executive Chairman

College Hill 020 7457 2020
Corinna Dorward




This information is provided by RNS
The company news service from the London Stock Exchange

Healthcare Enterprise Group PLC
11 March 2005

Healthcare Enterprise Group PLC

Announcement of notifiable interest of shares



Healthcare Enterprise Group PLC ('HCEG') was notified on 10 March 2005 that
Morgan Stanley Securities Limited has an interest of 4,934,000 ordinary shares
in HCEG, being approximately 3.29% of the issued share capital of the HCEG.



11 March 2005






This information is provided by RNS
The company news service from the London Stock Exchange

Ticking up nicely this morning. Next stop 150p ?

Anyone got any comment on the recent drop in HCEG?

dclinton lots of info on ADVFN.com

Not a member. Care to summarize here?

Drop in price down to tree shakes and small holders seeing the value of their stock dropping .Today there have been a lot of buying around the 94-97p range,me? I bought at 103 the other day but will hold as good news is just around the corner.HCEG is very difficult to call as there isn't anything similar to it,but a decent RNS and these will rise very quickly.If you haven't now is the time to take action and buy at the present levels.You've seen what happened last time and don't forget private shareholders only hold around 12% of the stock..If MW provides an upbeat comment in his newsletter then his followers will pile in.

I've been in HCEG for some time. The price has dropped through my 15% soft-stop-loss and I need to decide whether to cut and run with the profit I have left. The lack of news is worrying but I've been over to ADVFN and had a read there and, as you say, it looks like tree shaking.

The price seems to have stabalized at about 95 for the moment and I agree that good news should lift these again. From the chart, looks like a simple 50% retracement of the recent surge so I'll hold.

Doug

Where do any one think the price can go and is it a strong buy?

155p is the figure banted about. LOL DYOR

thanx

began picking up today bid been upto 108bid /112offer thought they would return now around 100p bid stil up on day at present have seen elsewhere and looks as MW may be updating shortly on his website,but only gossip.

Here is what Numis stated.
Buy
118p
Target Price: 155p
Market Capitalisation 177m
Shares in issue 150m

Healthcare Enterprise* Based on market rating for 06/7

Update to forecasts

We last published forecasts on this company in our note of 16th December, and since that date, the shares have been recapitalised on the basis of one share for every 25 held then.

Since December there have been a number of published developments, and the company has been very busy in seeking out new business, as well as developing its portfolio.

Its business model appears to be proving successful, with good cash flow from its occupational health and first aid business, financing the development of a number of exciting new products, generally coming out of various incubator systems.

The company appears now to be making excellent progress across the business, with its distribution operation going well, and a rapid early build-up in orders for Ebiox, plus positive developments from products in development, particularly Optiscope.

As a result of these positive developments, we feel that there is now a need to revise
upwards our earlier forecasts, and on the basis of anticipated further success with orders for Ebiox in particular, we expect significant profits for the financial year just started, plus substantial growth over the next couple of years.

If anyone can tell what has changed if nothing then we are at bargain prices.

The upsurge in Avian Flu...again...Ebiox???
Wait till elections over in U.K....NHS contracts...yes
Strong sp considering rest of market...one of my favorites...weakness yesterday due to issue of new shares?
I shall be very interested to see what the morrow brings...been waiting for some news from HCEG for a while now.
Ethel

Gossip states there is a cracking write up on www.michaelwalters.com tonight, anyone seen it, or in their own words post,please and not word for word from the site as it will offend.

If the above statement correct we'd better hold onto our hats.

This is some great news !
I emailed Dr. Gordon Woods today about the S.D.A and this was his answer :
( Check out his new American address as well )
Thanks for your e-mail.



We are indeed aware of the SDA, which is an organisation primarily for US based manufacturers.



Our Group Operations Director Paul Stuart (whom joined us from Bierdorf Smith & Nephew) has just returned from the US where he has finalised a manufacturing contract with a company called Custom Chemicals Inc. whom will begin to manufacture Ebiox for us in The United States.



As sales volumes in the US begin to increase, it no longer makes sense for us to manufacture the products in the UK and ship to the US (they have enough water of their own!)

Myself and Paul will travel to China next month with a view to establishing manufacturing facilities there for similar logistical and commercial reasons.



I can confirm that Custom Chemicals are members of the SDA.



Kind Regards



Dr.Gordon A Wood
Chief Executive Officer
Healthcare Enterprise Group PLC

That is the very best of news!!
Thanks substp